Circulating vascular endothelial growth factor is unaffected by acute hyperglycemia and hyperinsulinemia in type 1 diabetes mellitus

European Journal of Internal Medicine

Volumn 18, Issue 3, 2007, Pages 193-195

  Dullaart, Robin P F ^a   Oomen, Peter H N ^a   Sluiter, Wim J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Glucose; Insulin; Type 1 diabetes mellitus; Vascular endothelial growth factor

Indexed keywords

GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PROTEIN BLOOD LEVEL;

EID: 34247158188     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.11.006     Document Type: Article

References (17)

1. Aiello L.P., and Wong J.S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int 58 Suppl 77 (2000) S113-S119
2. Flyvbjerg A., Khatir D.S., Jensen L.J.N., Dagnaes-Hansen F., Gronbaek H., and Rasch R. The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease. Curr Pharm Des 10 (2004) 3385-3394
3. Chiarelli F., Spagnoli A., Basciani F., Tumini S., Mezzetti A., Cipollone F., et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: relation to glycaemic control and microvascular complications. Diabet Med 17 (2000) 650-656
4. Kakizawa H., Itoh M., Itoh Y., Imamura S., Ishiwata Y., Matsumoto T., et al. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 53 (2004) 550-555
5. Santilli F., Spagnoli A., Mohn A., Tumini S., Verrotti A., Cipollone F., et al. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. J Clin Endocrinol Metab 86 (2001) 3871-3876
6. Seckin D., Ilhan N., Ilhan N., and Erdogan S. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diabetes Res Clin Pract 73 (2006) 191-197
7. Ashraf A., Mick G., Meleth S., Abdullatif H., Wang X., and McCormick K. Effect of insulin on plasma vascular endothelial growth factor in children with new-onset diabetes. J Clin Endocrinol Metab 90 (2005) 4920-4923
8. Sörensen V.R., Mathiesen E.R., Clausen P., Flyvbjerg A., and Feldt-Rasmussen B. Impaired vascular function during short-term glycaemic control in type 1 diabetic patients. Diab Med 22 (2005) 871-876
9. Dorozo G., Russo I., Mattiello L., Anfossi G., Bosia A., and Trovati M. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance. Eur J Clin Investig 34 (2004) 664-673
10. Dandona P., Aljada A., Mohanty P., Ghanim H., Bandyopadhyay A., and Chaudhuri A. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. Diabetes Care 26 (2003) 3310-3314
11. Stehouwer C.D.A., Lambert J., Donker A.J.M., and Van Hinsbergh V.W.M. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34 (1997) 55-68
12. Blann A.D., and Lip G.Y.H. Cell adhesion molecules in cardiovascular disease and its risk factors-what can soluble levels tell us?. J Clin Endocrinol Metab 85 (2000) 1745-1747
13. Jilma B., Dallinger S., Hergovich N., Eichler H.G., Richter V., and Wagner O.F. Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endorinol Metab 85 (2000) 1748-17451
14. Oomen P.H.N., Kant G.D., Dullaart R.P.F., Tervaert J.W., Reitsma W.D., and Smit A.J. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus. Scand J Clin Lab Invest 64 (2004) 119-127
15. Coppola L., Coppola A., Grassia A.S., Mastrolorenzo L., Lettieri B., De Lucia D., et al. Acute hyperglycemia alters von Willebrand factor but not the fibrinolytic system in elderly subjects with normal or impaired glucose tolerance. Blood Coagul Fibrinolysis 15 (2004) 629-635
16. Ceriello A., Falleti E., Motz E., Taboga C., Tonutti L., Ezsol Z., et al. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 30 (1998) 146-149
17. Sampson M.J., Davies I.R., Brown J.C., and Hughes D.A. Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler Thromb Vasc Biol 22 (2002) 1187-1193